tirzepatide surmount-1 weight loss percent nejm 2022 for Obesity Treatment and Diabetes Prevention Retatrutide Phase 2 NEJM Trial:

Its filling human headlines and TikToks alike

Your doctor may also explore alternative compounds like tirzepatide (which acts on dual GLP-1 and GIP receptors) if semaglutide alone isn't meeting your goals at tolerable doses

Long-term use may be necessary for sustained weight management, especially for people with obesity or metabolic conditions

The key differences are the approved indication, the maximum dose, and how insurance handles each one

The clinical guidelines and recommendations from esteemed health organizations such as the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) consistently endorse the use of GLP-1 analogues for specific patient associates